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Abstract
Background: Data is needed about barriers to self-collection of Human Papillomavirus (HPV) samples and cytology
among low-income, disadvantaged women living in rural areas of lower-income countries as these women are at
increased risk of cervical cancer mortality.
Methods: Individual interviews (n = 29), focus groups (n = 7, 5–11 participants) and discussion groups (n = 2, 18–25
participants) were organized with women from three indigenous ethnic groups residing in rural areas in Mexico, after
they were provided with free, self-sampled HPV tests. These groups are low-income, underserved by healthcare and
have historically been on the receiving end of racism and social exclusion. Descriptive, qualitative content analysis was
done, including two cycles of coding.
Results: Interview and focus/discussion group data indicate women had limited understanding of HPV’s role in cervical
cancer etiology. They identified HPV’s existence, that cytology detects cervical cancer, the need for regular testing and
that cervical cancer is sexually transmitted. Organizational barriers to clinic-based cytology included irregular supplies of
disposable speculums, distance to clinics and lack of clear communication by healthcare personnel. Women
considered self-collected HPV-testing easy, less embarrassing and less painful than cytology, an opportunity
for self-care and most felt they understood how to take a self-sample after a 20-min explanation. Some women feared
hurting themselves when taking the self-sample or that they would take the sample incorrectly, which they worried
would make the test useless. Attending HPV-testing in groups facilitated use by allowing women to discuss their
doubts and fears before doing self-collection of the sample or to ask other women who were the first to do
the self-sampling what the experience had been like (whether it hurt and how easy it was). Lack of indoor bathrooms
was a barrier to doing HPV self-sampling at home, when those homes were resource-poor (one-room dwellings).
Conclusions: Low-income, indigenous Mexican women residing in rural, underserved areas identified their need for
cervical cancer screening but encountered multiple barriers to cytology-based screening. They found a number of
advantages of HPV self-sampled tests. Employing self-collected HPV-testing instead of cytology could resolve some but
not all gender-related, organizational or technical quality-of-care issues within cervical cancer detection and
control programs.
Keywords: HPV test, Cytology, Self-sample, Cervical cancer, Barriers to detection, Middle-income nations,
Qualitative methodology, Rural residence, Low-income, Underserved
* Correspondence: elazcano@insp.mx
6Center for Population Health Research, National Institute of Public Health,
Av. Universidad #655, Colonia Sta. Ma. Ahuacatitlán, 62508 Cuernavaca,
Morelos, Mexico
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Allen-Leigh et al. BMC Cancer  (2017) 17:734 
DOI 10.1186/s12885-017-3723-5
Background
Cervical cancer mortality has decreased in higher-income
nations, given cervical cancer screening programs employ-
ing periodic cytology and follow-up of abnormal results
[1]. Mortality rates have not declined in many middle-
and lower-income countries [2, 3]. Lower screening cover-
age is associated with disparities which can constitute
barriers to testing, including lower income and education,
residence in rural or low human development index areas,
belonging to indigenous groups or language and cultural
barriers [4–7]. Beyond coverage, continued high cervical
cancer mortality rates in lower-income countries are often
due to inefficient screening programs [8].
Implementation of high-risk human papillomavirus
(HPV) tests in screening programs could reduce mortal-
ity through more efficient early detection and treatment
[8–11]. In large, middle-income countries such as India
and Mexico, studies have shown clinician-administered
and self-collected HPV testing to be more cost-effective
than cytology alone [12]; when used in conjunction with
cytology they identify more high-grade lesions which can
progress to cancer [13]; and self-sampled HPV tests
compare favorably with physician-sampling or cytology
[11]. Also, studies have shown high acceptability of self-
sampled HPV tests with increased participation by non-
participating women [14, 15].
Given the advantages of HPV testing for lower-income
countries with high cervical cancer mortality, low cover-
age and quality-control problems [8, 11, 14–16], where
risk of dying of cervical cancer is often greater among
women in rural and underserved communities [4, 6, 7],
our objective was to study barriers to use of self-
sampled HPV testing and cytology among low-income,
indigenous women residing in rural areas of Mexico.
Methods
The study protocol was reviewed and approved by the
Research, Bio-security and Ethics Committees of the
National Institute of Public Health of Mexico. The data
from this study is not available for public consultation
because the informed consent text which was read to
participants included the statement: “Confidentiality: All
the information you give us (during the interview or
focus group) will be strictly confidential, meaning that
it will only be used by the researchers of this project
and will not be available for any other reason, except
for selected quotations which may be included in re-
search reports.”
Sample and participant recruitment
We recruited women 20-years and older from three ethnic
groups indigenous to Mexico, in three different states:
Mam women in Chiapas, Nahuatl speaking women in
Puebla and Huichol women in Jalisco. Mexico’s indigenous
population generally has lower incomes, is more often
illiterate or has not completed primary school and experi-
ences multiple socioeconomic disparities. Their communi-
ties tend to be underserved by healthcare and have
historically been on the receiving end of racism and social
exclusion [17]. We included indigenous communities in the
study since previous analyses had shown that women living
in rural areas, in marginalized communities and in lesser
developed parts of Mexico had a higher relative risk of
dying of cervical cancer [4, 7, 18]. Also, using the limited
data available, we were able to estimate that at the time of
the study the cervical cancer mortality rate among women
living in communities with higher proportions of indigen-
ous population in Mexico was approximately 17 deaths per
100 thousand women 25 years and over, [19–21] as com-
pared to a national rate of 9 deaths per 100 thousand
women [22].
The study communities were rural and had low levels
of human development, including limited access to qual-
ity healthcare. Most of the study communities had a
small, rural health center (offering limited primary care),
although two Nahuatl speaking communities in the
Sierra Norte region of the state of Puebla did not have
any health center in their community. Pap tests were
performed at these clinics, although previous research
indicates quality control at this type of rural health cen-
ter is basically nonexistent [16]. The Mam communities
in Chiapas and the Nahuatl speaking communities in
Puebla all had access to a small hospital (secondary level
care) in the capital of the municipality, while the
Huichol communities in Jalisco did not. Distances to
hospitals varied greatly, with some communities under
15 km from a hospital and others 50, 200 or 300 km
from a hospital providing secondary level care. The
communities generally had access to radio stations in
their native languages and to radio and television in
Spanish. Participants were low-income women from
these communities and their fluency in Spanish ranged
from proficient to non-existent.
This was a purposeful sample that sought to include
cases that were expected to be rich in valuable informa-
tion [23] given that these women are among those at
greatest risk of mortality due to cervical cancer, [4, 7, 18]
probably have greater barriers to early detection and treat-
ment of cervical cancer and are those whom self-sampled
HPV testing could potentially benefit most.
During 2007, upon arriving at each of the three re-
gions studied, two female anthropologists recruited local
female healthcare workers and bilingual residents to pro-
vide support with translation. Ten to fifteen days were
spent with each ethnic group, with at least 3 days spent
in each community or town. Some time was spent con-
tacting community elders or women’s organizations; field-
workers also travelled by foot through the communities
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with a megaphone (a method often used in rural commu-
nities in Mexico, to share news, offer services or goods for
sale) promoting the study. Time was then spent going
door-to-door to explain the study to women individually,
and to invite them to either do the free HPV test at home
(often rejected due to single-room homes with no privacy
such as an indoor bathroom to perform the self-sampled
test) or at a health clinic or other community center.
Women agreeing to participate could opt to do only the
free HPV test or to participate in an interview or focus
group as well. Verbal informed consent was requested in
the local language before participation; verbal consent was
used instead of written consent because many of the
women in the study population were illiterate.
At the health or community center, fieldworkers gave
a 20–30 min educational session on HPV, cervical can-
cer and how to do self-collection for the hybrid capture-
2 HPV test (specifying testing was free-of-charge with
results in 6 weeks). Fieldworkers used illustrations of the
self-sampled test being done by a woman, including an
internal drawing of the woman’s vagina with the swab
inserted, printed on large pieces of cardboard. All field-
workers performed the self-sampled HPV test on them-
selves at the beginning of the fieldwork, so they had
actual, personal experience of how the test was done,
before explaining it to the participants. Women then
performed the sample collection in a bathroom at home
(if they had an indoor bathroom) or in the community
center. Once placed in tubes with the buffer, samples
were collected by the female fieldworkers and trans-
ported by them to the municipal capital and from there
sent to a research laboratory for analysis. Results were
provided in 5–6 weeks by the female fieldworkers, who
returned to the study communities. Referrals for free cy-
tology (for diagnostic confirmation) and treatment at the
closest Ministry of Health clinic able to provide this care
were provided to all women with a positive HPV test.
Data collection
Nine focus or discussion groups (6 pre-testing, 3 post-
testing) and 29 interviews were carried out, as were 503
self-collected hybrid capture-2 HPV tests (detailed
information on data collection is available in a table [see
Additional file 1]). Focus groups (audio-recorded)
included 5–11 participants while discussion groups in-
cluded 18–25 women (given the size of these groups,
they could not be considered focus groups; also for this
reason, they were not audio-recorded, as audibility
would have been extremely limited). (Topics included in
guides for pre- and post-testing focus and discussion
groups and individual interviews are included in a table
[see Additional file 2]). The same female anthropologist
facilitated all focus groups, and another female anthropolo-
gist provided support and note taking. When interview and
focus or discussion group sessions were translated, tran-
scription was of the Spanish translation (for information on
which interviews and group sessions were translated, see
Additional file 1). Field-notes were taken during ses-
sions since conditions were often not conducive to
audio-recording.
Data analysis
We sought commonalities in the qualitative data, which
we segmented and distributed into categories in a two-
stage coding process using descriptive categories for
first-level coding and then pattern codes for second-
level coding (for specific codes used in each stage,
[see Additional file 3]). The pattern codes were based
on selected literature on HPV testing [24–27], the an-
thropology of health and illness [28, 29] and gender
theory [30, 31].
The data that was coded (in both stages) included
transcriptions of the individual interviews and focus
groups, and field notes taken during the discussion
groups, which registered the statements made by partici-
pants as faithfully as possible. During both stages of
coding, the transcriptions of audio-recordings and the
field-notes taken when audio-recording was unfeasible,
were read and re-read, and the codes were applied in
order to identify and label data corresponding to the a
priori categories, with some additional codes emerging
from the ethnographic material. During the first stage of
coding, the a priori codes were based on the topics of
the interview/focus group guides while during the sec-
ond stage, these codes were defined based on the litera-
ture review and theoretical framework. Next, segments
(of the transcriptions or field notes) that had been classi-
fied within the categories (labeled with the codes) were
grouped together and read through. For example, all the
segments labeled with the specific code “Beliefs and
knowledge about the cytology” were grouped together
and read through. During this reading of the segments
grouped by code or category, the first author interpreted,
summarized and selected quotations for inclusion in the
final write-up of the data [32].
Results
Results are organized around the following themes:
perceptions, beliefs and knowledge about cervical can-
cer and HPV; perceptions, knowledge and experiences
related to cytology; barriers to cervical cancer screen-
ing using cytology; gender barriers and acceptability
of the self-collected HPV test; perceived advantages of
the self-sampled HPV test (for selected segments of
the transcriptions or field-notes, grouped by topic or
category, see Table 1, for a longer list of segments,
[see Additional file 4]).
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Table 1 Selected quotations from focus groups and individual interviews, study on HPV and cytology among rural, indigenous women
in Mexico
Theme Subtheme Example quotation
Beliefs and knowledge about
cervical cancer
Correct knowledge “If you detect it in time, you can take that sickness out so it won’t
progress any more and with a treatment you are fine.”
(Interview with a Nahua woman)
Incorrect knowledge “Between these two sicknesses [HPV and cervical cancer] we’re
in danger, we should go to the clinic or a doctor. If we feel pain
in the womb, go to a doctor.” (Focus group with Mam women)
Perceptions of and knowledge
about the Human Papillomavirus
(HPV)
Correct knowledge [Cervical cancer is caused] “by infections, because later they
become like a tumor in the womb.” (Interview with a Mam woman)
“There is a vaccine for human papillomavirus. I heard it on the radio,
that there are vaccines.” (Interview with Huichol woman)
Combined correct and
incorrect knowledge
“Well, as far as I know, the virus is transmitted through sexual contact.
Then this human papillomavirus, it begins without any warning.
Then later it progresses, then the discomfort in our parts [genitals]
begins and that’s when the discharge starts and it progresses to
the cervix and when it gets to the cervix it goes into the uterus and
that is when the doctor sends us for an operation.”
(Interview with a Nahua woman)
Perceptions, knowledge and
experiences related to cytology
Combined correct and
incorrect knowledge
“Moderator: What is cervical cancer, what do you know about
cervical cancer?
Huichol woman 1: They say you can die of cancer, if you don’t
detect it early.
Moderator: And how do you detect it?
Huichol woman 1: With the Papanicolaou, doing it periodically.
Moderator: And what’s periodically?
Huichol woman 1: Every three months.
Moderator: Everyone, how often do you think you need to get a
Papanicolaou?
Huichol woman 2: Once a year.
Huichol woman 3: Depends on how you feel, once a year or every
two years, I get it every two years.
Moderator: What do you mean, how you feel?
Huichol woman 3: If you feel burning.” (Focus group with Huichol
women)
Barriers to cervical cancer
screening using cytology
or the HPV self-sampled test
Pain and fear of unsterile
equipment as a barrier
“[When they did the Papanicolaou test], maybe they did it wrong.
I don’t know, but I felt something like a scrape. Then I thought
maybe the equipment wasn’t disinfected. … I thought about it a
lot before doing it again, because I was afraid.” (Interview with a
Nahua woman)
Not receiving test results
as a barrier
“A lot of us say, and we’ve talked about this before, when we get a
Papanicolaou, the results don’t arrive, and we don’t know what it is
that’s going on. There we are with the doctor, asking why the results
don’t arrive.… Whatever it [the result] is, they should give it to me.”
(Interview with a Mam woman)
Unequal gender relations
as a barrier
“The first time I went to check myself, with the Papanicolaou tests,
I had problems. I got beat-up. My husband hit me because he said
I had gone to do things with the [male] doctor. When it wasn’t
even a doctor who examined me, the [female] nurse examined me!
She took the sample, but at home my husband didn’t believe that.”
(Interview with a Nahua woman)
Lack of gender-related
barriers
“Because with all these [health education] talks they give us, women
are more secure in themselves. So, we don’t really ask men for
permission anymore, because it’s something that’s good for us.”
(Interview with a Huichol woman)
“I decided it [to perform the HPV test] myself, alone. I don’t ask
anyone’s permission. … How am I going to ask him if he
[her husband] wants it or not? It’s not for him, it’s for me.”
(Interview with a Nahua woman)
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Perceptions, beliefs and knowledge about cervical cancer
and human papillomavirus
All Nahua women interviewed knew of the existence of
cervical cancer and many had heard of someone from a
Nahua community dying from it. Many Nahua women
mentioned their fear of cervical cancer, the need to have
cytology in order to “detect it in time” (repeating phrases
in Spanish from health education campaigns) and the
existence of effective treatment. When asked about the
causes of cervical cancer, Nahua women mentioned that
“it comes from having lots of children”, “infection from
your husband” or “because sometimes we’re with a lot of
men”, although others said they had “forgotten” what
causes it. Many Nahua women linked lack of hygiene
with cervical cancer, said it was sexually transmitted and
was asymptomatic during initial stages. In general,
Nahua women (who also spoke more Spanish) had more
correct and complete knowledge than the other two eth-
nic groups.
The Mam women mentioned both traditional and allo-
pathic treatments for cervical cancer, seeming to prefer
the former and fear the latter. One Mam woman seemed
unconvinced of the efficacy of biomedical treatment for
cervical cancer (perhaps also doubting its treatability).
Another Mam woman spoke about “early detection” and
“prevention” of cervical cancer, but later said she didn’t
know what cervical cancer was, what caused it or if it
could be cured. She repeated some of the information
given the day before by the fieldwork team, but didn’t
appear to have been convinced about the usefulness of
testing. Misconceptions among the Mam women in-
cluded that cervical cancer is caused by miscarriage or
problems during childbirth and also lack of knowledge
about the existence of an asymptomatic period during
the development of cervical cancer.
The Huichol women spoke mainly of traditional treat-
ments for cervical cancer, but generally considered it
incurable or were doubtful of the efficacy of either trad-
itional or allopathic treatments. However, two Huichol
women expressed the desire to see if allopathic treat-
ment was more effective and suggested combining the
different types of treatment. In general, the Huichol
women did not say they knew women who had been
treated for or died of cervical cancer. The Huichol
women mentioned the following as causes of cervical
cancer: marrying very young, having many children, having
vaginal infections, the last of which they said “come from
not knowing who your man is with”.
Many of the Nahua women interviewed had received
health education about HPV, knew HPV is sexually
transmitted and identified a link between HPV and
cervical cancer. Mam women generally had not heard of
HPV although a few did say that a “virus” or “infection”
causes cancer or tumors. Several Huichol women had
heard of HPV, and generally spoke of beliefs and know-
ledge that combined traditional and scientific informa-
tion. One Huichol woman said the following in response
to a question asking what HPV is, “they are little, tiny
animals. We don’t know what they are.” However, other
women from this ethnic group stated that HPV causes
cervical cancer and is sexually transmitted, and some
knew an HPV vaccine exists.
Perceptions, knowledge and experiences related to cytology
The Nahua women generally identified cytology as a
diagnostic tool for detection, not confusing it with a
treatment; some mentioned it detected simply illness or
women’s illness, others said it detected cancer and some
referred to cervical cancer specifically. Quite a few
Nahua women mentioned that if cervical cancer were
detected it was possible to treat it, through surgery,
many mentioning hysterectomy and some describing less
invasive surgical procedures. However, two Nahua
women who had never had cytology in their lives (but
did agree to have an HPV test), seemed to perceive the
test as a way to prevent cancer or as a treatment instead
of a diagnostic tool. Mam women generally knew what
cytology was for, distinguishing it from prevention and
mentioning that cervical cancer should be detected
before it progresses to a more severe stage. While one
Mam woman evidenced knowledge about a stage when
cervical cancer lacks symptoms another woman showed
Table 1 Selected quotations from focus groups and individual interviews, study on HPV and cytology among rural, indigenous women
in Mexico (Continued)
Theme Subtheme Example quotation
Perceived advantages of the
self-sampled HPV test
Less embarrassment “This one [the HPV test] is good because it [cytology or the
Papanicolaou test] really does embarrass you, not because your
husband doesn’t want it or doesn’t let us, but because it’s
embarrassing and because of embarrassment we don’t do it, and
so this [self-sampled HPV test] is good for us.”
(Interview with a Huichol woman)
“because you do it yourself, since always, even if there is trust,
you feel a little embarrassed to undress in front of someone else”
(Interview with a Nahua woman)
More comfortable “Well, this one [the self-sampled HPV test] is better, because it
is more comfortable to do it.” (Interview with a Mam woman)
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a lack of this knowledge. In contrast, the Huichol
women generally perceived cytology as a way to prevent
cervical cancer or as a treatment for incipient cervical
cancer, confusing detection with prevention or treat-
ment. Although the concept of detection did not appear
to be clearly understood, the Huichol women did link
regular cytology use to prevention of morbidity (tumors,
bleeding and the need for a hysterectomy) and of mor-
tality due to cervical cancer. At the same time, they were
unclear as to how often the test should be performed
and about the need for periodic testing even in the
absence of symptoms.
Women of all three ethnic groups reported limited
previous gynecological healthcare. By far the most com-
monly mentioned type of care received was cytology,
with little use of other types of care. Women generally
used traditional birth attendants (midwives without
formal training) for obstetric care, and giving birth in
hospitals was only mentioned in a few cases. Some
women who experienced complications were unable to
access professional obstetric care, due to distance to the
hospital and lack of an ambulance.
Across the three ethnic groups, many women re-
ported undergoing cytology three-to-six times in their
lives, generally in the recent past. However, one or
two women in each ethnic group had never under-
gone cytology.
The participants’ had varied experiences of cytology
collection: some women said healthcare personnel were
respectful, explained the procedure, and that sample col-
lection was slightly embarrassing but not painful. Others
described cytology as extremely embarrassing and pain-
ful, and said healthcare personnel did not use disposable
speculums, but “only washed them and reused them”,
which was perceived as unhygienic.
Across the three ethnic groups, the women repeat-
edly mentioned that the healthcare system either took
an inordinately long time to give them their cytology
results, or did not provide them with their results un-
less they were positive. They coincided in that this
was unacceptable and that it discouraged them from
having regular cytology.
Barriers to cervical cancer screening based on cytology
Women living in communities without a local health
clinic mentioned distance (travel cost and time) to
clinics as an important barrier to regular cytology use. In
communities with a clinic, some women said that dis-
tance to hospitals was a barrier to treatment of cervical
cancer if detected. Women with limited Spanish fluency
mentioned a lack of healthcare personnel who spoke
their language as something that made cytology difficult.
Women also said they had difficulty understanding test
results and treatment recommendations, which were
explained in unfamiliar terms. Women who were illiterate
mentioned that test results and treatment recommen-
dations were sometimes given to them in writing,
which meant they had to consult someone literate to
understand them.
A significant barrier to regular cytology was the lack
of a supply of disposable speculums at health clinics.
Women said that sometimes when they arrived for a
cytology appointment, they were told that the clinic had
run out of disposable speculums and the woman would
either have to buy one herself (this was considered
prohibitively expensive) or return another day. Some
women also said they did not have the economic
resources to cover the cost of purchasing medicines to
treat sexually transmitted infections detected during the
pelvic exam for cytology. A few women complained of
long waiting times for a cytology appointment and
others said that women in the governmental poverty re-
duction program (now called Prospera, previously called
Oportunidades among other names) were given priority
over them, which meant they had to wait until those
women had seen the physician, before they were seen.
Gender barriers and acceptability of the self-collected
HPV test
In the three ethnic groups there were gender issues that
constituted barriers to previous cytology use or to
acceptability of the self-collected HPV test. In all three
ethnic groups there were some women who said they
needed to “consult” their husband or “ask his permis-
sion” before deciding to have the HPV test or cytology.
Among the Nahua women this was less common. When
the self-collected HPV test was offered, one Nahua
woman was undecided about whether to accept the test,
and made up her mind based on her teenage daughter’s
encouragement that she could make the decision on her
own. In a number of cases when husbands were present
in the home when the HPV test was offered to Nahua
women, the men made comments that indicated they
were supportive of or pleased with the idea of the
women having the test. However, quite a few Mam
women hid the fact that they were having the HPV test
from their husbands. Some Mam women said they spoke
with their husbands about getting cytology and that if he
did not approve they would do it without his knowledge,
hiding this fact from him. Although quite a few Huichol
women said they needed to consult or discuss with their
husband whether to have the HPV test, fewer said they
needed his “permission” than among the Mam women.
Huichol women mentioned discussing the decision with
other family members, and appeared to want to make a
group decision about the issue. However, other Huichol
women said they decided individually what to do.
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Perceived advantages of the self-collected HPV test
Levels of acceptance of the HPV self-sample test were
high, since among Mam women, 181 were offered the
test and 15 refused; among Huichol women 135 were
offered the test and 10 refused and among Nahuatl
speaking women 223 were offered the test and 21 re-
fused. We did not find patterns in terms of acceptability
or perceived advantages of the self-collected HPV test
among the women in terms of age or formal education,
although since our study was qualitative the sample was
small and with small numbers of women in each age
group. Variability of education level was limited since
most women had few years of formal education and
were illiterate.
Nahua women said the self-collected HPV test was
less embarrassing than cytology, given there was no need
for undressing or a pelvic exam. Other Nahua women
mentioned as advantages that they knew their own bod-
ies better than healthcare personal and that the self-
collected HPV test offered the opportunity for self-care.
Huichol women also generally perceived the self-
collected HPV test as less embarrassing and less painful
than cytology. Nahua women concluded that a test they
could perform themselves would tend to be less painful
(since “we know each part of ourselves to do it, because
… we know how to do it to ourselves better, we know
how to do it.”) and in general more comfortable. Other
women discussed the idea that the self-collected HPV
test offered them the opportunity for self-care.
While the Nahua and also the Huichol women per-
ceived the self-collected HPV test as “easy to use” and
felt they could perform the sample collection correctly,
the Mam women were divided, with some perceiving it
to be easy to use and others having doubts about their
ability to do the test correctly. The women who had
doubts about how to do the self-collected test feared
they might hurt themselves or that if the didn’t collect
the sample correctly, the test would be useless.
Lack of indoor bathrooms was a barrier to doing HPV
self-sampling at home, when those homes were resource-
poor (those with one-room dwellings, with an outdoor
latrine with no lighting). This led many women to opt for
doing the self-sampled test at a location in the commu-
nity, such as a health clinic (if one existed) or other com-
munity center. Related to this, an important advantage
perceived by many of the indigenous women who partici-
pated in the study, which was not directly related to the
HPV test being self-sampled, was that women attended
the testing sessions in groups, instead of alone. For some
women, this meant they could discuss their fears and
doubts with other women before doing the test, which
helped them decide to go through with it. Some women
said they asked others after they had done their own self-
collection what it had been like; when women who had
gone before said the test was not painful and that they felt
it was easy to do, others felt “encouraged” and decided to
do the self-collection themselves.
Discussion
Our study revealed a series of barriers to cervical cancer
screening among low-income, indigenous women resid-
ing in underserved, rural communities. One type of bar-
rier was incomplete knowledge: about HPV infection,
cervical cancer etiology (existence of an asymptomatic
period) and effective treatments. Facilitators related to
knowledge included identifying early detection as im-
portant (even without specifically recognizing the need
for testing in the absence of symptoms). Some women
confused cytology (detection) with treatment, but this
would not necessarily constitute a barrier to participa-
tion in screening. Organizational barriers to cytology
included distance to clinics, use of comprehensible lan-
guage by health personnel, long waiting times and delays
in receiving test results (undermining motivation for fu-
ture testing) and lack of disposable speculums at clinics.
Specifically for the self-sampled HPV test, doubt about
correctly collecting the sample or about if they might
hurt themselves when doing the self-collection was a
barrier for a few women. These issues in general indicate
a need for additional counseling and health education;
materials such as a manual and guidelines specifically on
counseling for HPV testing (including the self-sampled
option, and also including information about cervical
cancer etiology, treatments and cytology) should be pro-
vided to healthcare workers, with advice on how to com-
municate this information in very simple terms [33].
The need for counseling and health education before
and after HPV testing is done has been identified in
other studies [34, 35]. The actual ability of the women
participating in this study to carry out a self-sampled
HPV test correctly is not in doubt, given that many
other studies have shown that women can conduct self-
collected samples which result in similar levels of accur-
acy as clinician-collected samples, in terms of detecting
cervical intraepithelial cancer 2 or higher [36]. The issue
studied here was whether women felt (or perceived) they
would be able to do the self-sampling correctly; some
had confidence in their ability while others did not, and
participating as a group in the testing process was an
important facilitator in terms of gaining confidence in
being able to do the test correctly. Other studies have
found lack of confidence in doing the test correctly
among some, but not all, women; counselling and health
education are usually recommended and have been
found to increase confidence and acceptability [37–40].
We did not find patterns of acceptability of the self-
sampled HPV test in terms of women’s age or formal
education; other (quantitative) research has established
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that women’s age and education is not necessarily re-
lated to acceptability of HPV self sampled tests, [37]
although is some populations age is a factor [41].
Differences between the three cultural groups studied
were limited, and appear to be more a function of lan-
guage proficiency than anything else. Nahua women
more frequently identified that screening could detect
cervical cancer in early stages when treatment would be
effective. More Nahua and Mam women identified treat-
ments for cervical cancer and believed they would be ef-
fective. Huichol women were more often unconvinced
or unsure that cervical cancer can be detected in time
and/or believed treatment to be ineffective. The similar-
ities found may be due in part to the similar socio-
economic situation these different ethic groups live in,
including the tendency for their communities to be
underserved by healthcare, receive racist treatment and
be economically disadvantaged or low-income both at
the individual and community levels.
Facilitators or ways in which self-sampled HPV tests
could resolve barriers to cytology-based screening in-
cluded experiencing less embarrassment or pain. Male
partner opposition to a woman carrying out a cervical
cancer test was not always resolved by the HPV test be-
ing self-sampled. This might indicate that when women
give their male partner’s rejection of the pelvic exam as
their reason for not having a Pap test, it may not be so
simple. That is, there may be a combination of factors,
including men’s attempts to control their female part-
ner’s actions but also that the woman herself may not
want to undergo a pelvic exam or another type of test,
but finds her male partner’s rejection of it more socially
acceptable than her own. The gender issues related to
HPV and Pap test use are complex; while it appears clear
that women’s empowerment will contribute to greater
use of cervical cancer detection methods, including HPV
testing, quality of care issues may be of equal, or perhaps
greater, importance.
Also, women in this study saw attending screening in
groups as an important facilitator. Attendance in groups
allowed the women to discuss amongst themselves their
doubts and fears before doing the self-collection of the
sample or to ask women who were the first to do the
self-sampling what the experience had been like (whether
it hurt and how easy it was). Controlled trials of different
group care models have shown that they reduce costs,
achieve higher patient satisfaction, improve adherence to
physician recommendations and in some cases produce
improved health outcomes [42–45].
Other studies have found a variety of barriers to cer-
vical cancer screening using cytology which are similar
to those found in our study, such as lack of transporta-
tion, embarrassment, physical discomfort or pain during
cytology, language barriers and lack of knowledge about
screening [14, 15, 46]. Studies have generally found that
women have high acceptance rates and positive attitudes
towards self-sampled HPV tests; the most common dis-
advantage perceived by women (also found in our study)
is being uncertain about performing the test correctly
(fear of hurting themselves or taking the sample wrong
and thereby making the test useless) [15, 26–34].
An important limitation of this study is that transla-
tion was done by local residents who had at most a
secondary-level education (not professionals). This may
have led to less in-depth data, omissions or modification
of what women meant to express. However, since our
research team found no other options for translation, we
decided it was an acceptable alternative given the im-
portance of obtaining data on this population, which is
at greater risk of cervical cancer mortality. Given how
recruitment was carried out, participants may have
tended to be women who are more concerned about
their health, have a more preventive mind-set, know
more about the topics being studied and have a part-
ner with more positive views about cytology and HPV
testing. In addition, there may have been social desir-
ability bias in the responses given; that is, women
may have tended to say what they thought interviewers
wanted to hear.
Conclusions
HPV testing on self-collected samples has been shown
to be an effective cervical cancer screening test for
primary screening (with sensitivity comparable to
clinician-collected samples, when a PCR-based test is
used) [47, 48]. It could make high quality cervical cancer
screening available to women with the greatest barriers:
non-participant and underserved women, those with
greater healthcare disparities and levels of poverty [4, 14,
15, 49, 50]. Incorporation of both self-sampled and
healthcare personnel-collected HPV tests into cervical
cancer screening programs in middle- and lower-income
countries could be especially pertinent, given the burden
of cervical cancer, lack of infrastructure and of adequate
quality-control [13, 49]. The evidence suggests lower-
income countries use HPV tests for cervical cancer
screening, instead of cytology (which requires infrastruc-
ture that is unavailable and quality control which has
been unsuccessful in these contexts) [8, 13, 16] or visual
inspection (given its inaccuracy and potential for under-
and over-treatment) [8, 42, 50]. Including a self-sampled
HPV test for some women could make greater screening
coverage possible while maintaining high quality, as well
as resolving some of the barriers to cytology, as shown
by our findings. Nevertheless, effective structures to
guarantee adequate supplies, transport of samples, com-
munication of results and in general the triage and
follow-up system for women with positive results must
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be in place [13, 43, 49, 51]. In addition, innovative triage
strategies as well as the combination of vaccination and
screening for adult women (in addition to vaccinating
girls) should be explored through studies to confirm
cost-effectiveness and safety issues [51, 52]. In addition,
culturally appropriate health education and counseling
will remain important. Implementation studies and
demonstration projects are needed in these areas to
ensure the uptake of evidence-based detection methods
for cervical cancer, and to guarantee that follow-up
care (triage, including confirmatory diagnosis and
treatment) is provided.
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